Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.661 USD | -1.47% | -2.40% | +67.92% |
Apr. 12 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
Apr. 11 | Top Premarket Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.92% | 25.3M | |
-3.16% | 102B | |
+1.30% | 96.29B | |
+2.13% | 22.18B | |
-15.67% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.52% | 16.36B | |
+5.58% | 13.97B | |
+33.13% | 12.17B |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial